Importance: Since Dobbs v Jackson Women's Health Organization (Dobbs) removed federal abortion protections, people's views about alternative models of abortion care may have been impacted, yet research on this topic is limited.
Objective: To examine changes in national support for and personal interest in advance provision (AP) and over-the-counter (OTC) access to medication abortion.
Design, Setting, And Participants: Two nationally representative cross-sectional online surveys were administered to a market research firm's panel members who were assigned female at birth (AFAB) and aged 15 to 49 years from December 2021 to January 2022 (before Dobbs) and June to July 2023 (after Dobbs). Data were analyzed from February 2023 to June 2024.
Exposure: Completion of survey before and after Dobbs.
Main Outcomes And Measures: Changes from before to after Dobbs in 4 primary outcome measures were examined: support for and personal interest in AP and OTC access to medication abortion.
Results: A total of 6982 AFAB people before Dobbs and 3561 after Dobbs completed at least 1 of 4 primary outcome measures. From before to after Dobbs, 2666 (weighted 31.3%) and 1258 (weighted 30.1%) were aged 30 to 39 years, 1395 (21.4%) and 708 (21.5%) reported their race and ethnicity as Hispanic/Latinx, 594 (13.7%) and 304 (13.6%) as Black non-Hispanic/Latinx, and 4504 (54.6%) and 2270 (54.2%) as White non-Hispanic/Latinx. There was a significant increase from before to after Dobbs in national support for AP (48.9% before; 95% CI, 47.1% to 50.6%; 55.1% after; 95% CI, 52.8% to 57.3%) and OTC access (49.4% before; 95% CI, 47.6% to 51.1%; 55.2% after; 95% CI, 52.9% to 57.5%) and an increase in personal interest in AP (23.6% before; 95% CI, 22.2% to 25.1%; 26.4% after; 95% CI, 24.3% to 28.4%) and OTC access (36.0% before; 95% CI, 34.3% to 37.6%; 42.5% after; 95% CI, 40.2% to 44.7%). Among people living in states with abortion bans, larger increases in personal interest in AP (5.3 percentage points [pp]; 95% CI, 0.5 to 10.3 pp) and OTC access (9.4 pp; 95% CI, 3.9 to 14.9 pp) were observed than among people in states without bans (1.4 pp; 95% CI, -1.7 to 4.6 pp and 5.4 pp; 95% CI, 2.0 to 8.9 pp, respectively).
Conclusions And Relevance: In this serial cross-sectional analysis of people aged 15 to 49 years before Dobbs and 1 year after Dobbs, findings suggested that national support for expanded access to medication abortion has grown. Alternative models of care, such as AP and OTC, have the potential to offer a promising approach to abortion care, particularly for people living in abortion-restricted states.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1001/jamanetworkopen.2024.54767 | DOI Listing |
JAMA Netw Open
January 2025
Advancing New Standards in Reproductive Health, University of California, San Francisco, Oakland.
Importance: Since Dobbs v Jackson Women's Health Organization (Dobbs) removed federal abortion protections, people's views about alternative models of abortion care may have been impacted, yet research on this topic is limited.
Objective: To examine changes in national support for and personal interest in advance provision (AP) and over-the-counter (OTC) access to medication abortion.
Design, Setting, And Participants: Two nationally representative cross-sectional online surveys were administered to a market research firm's panel members who were assigned female at birth (AFAB) and aged 15 to 49 years from December 2021 to January 2022 (before Dobbs) and June to July 2023 (after Dobbs).
Drug Alcohol Depend
December 2024
Department of Implementation Science, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Background: Over-the-counter (OTC) naloxone became available for sale at community pharmacies in September 2023. This study examines whether naloxone availability and cost are associated with pharmacy type (independent vs chain), pharmacy rurality, and their interaction.
Methods: Using a cross-sectional secret shopper study design, data were collected by phone from a stratified random sample of 600 community pharmacies in North Carolina from November 2023 to January 2024.
Lancet Public Health
January 2025
US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Background: Rapid, accessible, and accurate testing was paramount to an effective US COVID-19 response. Federal partners supported SARS-CoV-2 testing scale-up through an interagency-coordinated approach that focused on expanding supply chains, research and development, validation, and improving patient access. We aimed to provide an overview of the federal efforts to scale up the testing response and study the impact of scale-up.
View Article and Find Full Text PDFPLoS One
December 2024
SGH Warsaw School of Economics, Warsaw, Poland.
The study examines different graph-based methods of detecting anomalous activities on digital markets, proposing the most efficient way to increase market actors' protection and reduce information asymmetry. Anomalies are defined below as both bots and fraudulent users (who can be both bots and real people). Methods are compared against each other, and state-of-the-art results from the literature and a new algorithm is proposed.
View Article and Find Full Text PDFNanoscale
December 2024
School of Environmental and Chemical Engineering, Jiangsu University of Science and Technology, Zhenjiang 212003, China.
Multiple functional tailored materials have shown great potential for both pollutant degradation and freshwater recovery. In this study, we synthesized densely distributed Co onto carbon-layer-coated Ni/AlO hydrangea composites (Ni/AlO@Co) the polymerization of dopamine under a controlled graphitized process. The characterization results revealed that Ni/AlO@Co, with abundant exposed bimetallic Co-Ni species on the surface of AlO, could afford accessible catalytic sites for persulphate activation and subsequent pollutant degradation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!